He is alluding to them dramatically changing the vaccines AFTER Trump left office. This is evident as they continued to roll out many different vaccines (boosters)
Not quite.
The COVID-19 shots were rolled out under Emergency Use Authorization (EUA), not the normal 8–10 year FDA approval pipeline. That means the typical long-term clinical trials, multi-year observation periods, and post-market safety review windows were skipped or condensed. Later, the FDA announced “full approval” of Pfizer’s Comirnaty in 2021, but that approval was largely on paper—the product branded “Comirnaty” was not actually distributed to the public in any meaningful quantity. Instead, the vaccines that continued to be administered remained under EUA labeling.
In other words, the technical “approval” existed, but the fully tested, standard-channel FDA-approved version wasn’t what was going into arms. What people got was the emergency use version, not a product that had cleared testing.
There was a bait and switch from the start. They were never giving out the one that eventually got approval.
We had the exact same rate of vaccine adverse event reports from day one that we had years later. Approximately 5% of lot #'s / batches (or 1 out of 20) were bad and causing over 90% of hospitalizations. This was virtually identical across all three different main brands of vaccines. You can look this up for yourself on the governments vaers database.
Not quite.
The COVID-19 shots were rolled out under Emergency Use Authorization (EUA), not the normal 8–10 year FDA approval pipeline. That means the typical long-term clinical trials, multi-year observation periods, and post-market safety review windows were skipped or condensed. Later, the FDA announced “full approval” of Pfizer’s Comirnaty in 2021, but that approval was largely on paper—the product branded “Comirnaty” was not actually distributed to the public in any meaningful quantity. Instead, the vaccines that continued to be administered remained under EUA labeling.
In other words, the technical “approval” existed, but the fully tested, standard-channel FDA-approved version wasn’t what was going into arms. What people got was the emergency use version, not a product that had cleared testing.
There was a bait and switch from the start. They were never giving out the one that eventually got approval.
We had the exact same rate of vaccine adverse event reports from day one that we had years later. Approximately 5% of lot #'s / batches (or 1 out of 20) were bad and causing over 90% of hospitalizations. This was virtually identical across all three different main brands of vaccines. You can look this up for yourself on the governments vaers database.
And, the bad lots seemed to rotate between the brands such that only one of them was doing most of the damage over a given period.